US Stock Market Move | Lilly (LLY.US) rises more than 5% as CVS Health Corporation's health recovery weight loss drug Zepbound is covered by medical insurance.
On Thursday, Eli Lilly (LLY.US) rose more than 5%, closing at $1138.23.
On Thursday, Eli Lilly (LLY.US) rose more than 5% to $1138.23. In terms of news, US healthcare giant CVS Health Corporation announced today that its pharmacy benefits management division CVS Caremark will update its commercial formulary to include coverage for Lilly's popular weight loss drug Zepbound and also the new daily oral weight loss drug Foundayo. This move is aimed at providing policyholders with a wider range of GLP-1 class medication options and to increase market competitiveness.
Related Articles
YUM CHINA (09987): David Hoffmann appointed as a member of the Compensation Committee.
C FIN SERVICES (00605): Janie Lee has resigned as an independent non-executive director.
CN INT DEV CORP(00264) has signed a joint venture agreement for developing artificial intelligence data center business in Southeast Asia.
YUM CHINA (09987): David Hoffmann appointed as a member of the Compensation Committee.
C FIN SERVICES (00605): Janie Lee has resigned as an independent non-executive director.
CN INT DEV CORP(00264) has signed a joint venture agreement for developing artificial intelligence data center business in Southeast Asia.
